GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 23 filers reported holding GAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $434 | 0.52% |
| Greenlight Capital | 546,560 | $2,634,419 | 0.14% |
| Wealth Alliance Advisory Group, LLC | 12,502 | $60,260 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $280,042 | 0.02% |
| Cannell Capital | 12,371 | $59,628 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $289,200 | 0.01% |
| NewEdge Advisors, LLC | 10,500 | $54,075 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,844 | $33 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 94,207 | $454,077 | 0.00% |
| MORGAN STANLEY | 800 | $3,856 | 0.00% |
| BlackRock Inc. | 24,778 | $119,430 | 0.00% |
| Citadel Advisors | 12,800 | $61,696 | 0.00% |
| Citadel Advisors | 100 | $482 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,172 | $73,129 | 0.00% |
| Citadel Advisors | 17,447 | $84,095 | 0.00% |
| Renaissance Technologies | 38,700 | $187 | 0.00% |
| ROYAL BANK OF CANADA | 39,000 | $188,000 | 0.00% |
| VANGUARD GROUP INC | 52,605 | $253,556 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 20,000 | $96,400 | 0.00% |
External links
This page lists GAIN THERAPEUTICS INC's shareholders in Q1 2023. To view GAIN THERAPEUTICS INC's shareholder history, click here.